---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-020569"
form_type: "8-K"
ticker: "FEED"
cik: "0001326706"
company_name: "ENvue Medical, Inc."
filed_at: "2025-07-22T23:59:59+00:00"
generated_at: "2026-05-18T04:10:07.873634+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# NanoVibronix raises $8M in private placement of Series H convertible preferred and warrants

## Summary
- Initial closing of $8M gross proceeds: 8,889 Series H preferred shares ($1,000 stated value, convertible at $1.01/sh) and warrants for 4,678,363 shares at $2.25/sh.
- Second closing of $2.22M (2,222 preferred shares) contingent on customary conditions.
- Net proceeds: $5M to redeem Series X preferred stock; remainder for working capital.
- Investor gets right to buy up to $44M additional preferred stock over 36 months at 85% of average VWAP.
- Company must seek stockholder approval for issuance exceeding 19.99% of outstanding common stock.

## SEC filing metadata
- accession: 0001641172-25-020569
- form_type: 8-K
- ticker: FEED
- cik: 0001326706
- company_name: ENvue Medical, Inc.
- filed_at: 2025-07-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 3.03, 5.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326706/000164117225020569/0001641172-25-020569-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326706/000164117225020569/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-020569
- JSON: https://secwatch.observer/filing/0001641172-25-020569.json
- Plain text: https://secwatch.observer/filing/0001641172-25-020569.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.